Skip to content

Three-Dimensional Analysis of Midfacial Soft Tissue Changes after maxillary advancement through conventional or high Le Fort I osteotomy

Three-Dimensional Analysis of Midfacial Soft Tissue Changes after maxillary advancement through conventional or high Le Fort I osteotomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250505065613N1
Enrollment
20
Registered
2025-08-06
Start date
2025-08-06
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Jaw deformity requiring orthosurgery. Condition 2: Skletal class 3 deformity. Major anomalies of jaw size Other congenital deformities of skull, face and jaw

Interventions

Intervention 1: Intervention group:In this group, the High Lefort 1 osteotomy method will be used, which we expect to lead to better and greater imp.rovement of paranasal and anterior and lateral and

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients with Skeletal Class III malocclusion due to maxillary deficiency who have undergone maxillary advancement surgery

Exclusion criteria

Exclusion criteria: Age over 40 years Maxillofacial Malformation lip and palate cleft Maxillofacial fracture following trauma History of Rhinoplasty Need for maxillary impaction Systemic diseases and dermatological disorders that affect the tissues and appearance of the face severe facial asymmetry multi piece lefort 1 osteotomy

Design outcomes

Primary

MeasureTime frame
Changes in paranasal tissues. Timepoint: At the beginning of the study and 6 months later. Method of measurement: Clinical measurement and Cone beam computed tomography (CBCT)imaging.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSadegh khodaee

Shahid Beheshti University of Medical Sciences

Dr.s.khodaee@gmail.com+98 21 2217 5351

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026